Compare Prima Andalan Mandiri Tbk. (MCOL) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Prima Andalan Mandiri Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Prima Andalan Mandiri Tbk. trades at Rp3,690 (market cap 13.19T, 22.6K 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Prima Andalan Mandiri Tbk. is far larger — about 126.3× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| MCOL | SCPI | |
|---|---|---|
Market Cap | 13.19T | 104.4B |
Volume | 22.6K | — |
Lot | 226 | — |
Turnover | 82.96M | — |
Average Price | 3,670.71 | — |
Value | 82.96M | — |
Indicative Equilibrium Price | 3,690 | — |
Indicative Equilibrium Volume | 5 | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Prima Andalan Mandiri Tbk.
PT Prima Andalan Mandiri Tbk (the Company) is a limited liability company established in the Republic of Indonesia based on Notarial Deed of Nurul Hidajati Handoko, S.H., No. 1 dated June 1, 2005. The Company started commercial activities in 2011.
Read more on MCOL →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
